[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)

MoonLake Immunotherapeutics (MLTX) sees significant social media buzz and price action driven by buyout speculation and a recent stock offering, despite mixed clinical trial results.

About MoonLake Immunotherapeutics Class A Ordinary Shares

MoonLake Immunotherapeutics is a biotechnology company focused on developing and commercializing novel immunotherapies.
MoonLake Immunotherapeutics Class A Ordinary Shares uses the ticker $MLTX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) trading volume is up XXXX% from the previous week.
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) social dominance is up XXXXXX% from the previous week.
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) sentiment is up XXXXXX% from the previous year.
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) engagements is up XXXXXX% from the previous week.
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) posts created is up XXX% from the previous week.

Price: $XXXXX

Price 24-Hour Time-Series Raw Data
The current price surge is attributed to speculation of a potential buyout or short squeeze, coupled with a successful stock offering. Recent social posts indicate institutional buying and positive outlooks on FDA approval, which are currently outweighing negative clinical trial results.

24-Hour: -XXXX% 7-Day: XXXX% 30-Day: XXXXX%

1-Year High: $XX on 2025-09-26
1-Year Low: $XXXX on 2025-09-29

AltRank: XXXXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) is currently AltRank #1,654 based on combined combined social and market metrics Daily Average: XXX
X Week: XXXXX -XX
X Month: XXXXX +515
X Months: XXXXX +1,229
X Year: XXXXX +221
1-Year High: XXXXX on 2025-03-08
1-Year Low: XX on 2025-09-29

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX -XX
X Year: XX -X
1-Year High: XX on 2025-04-21
1-Year Low: XX on 2025-01-08

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXXX
X Week: XXXXXX +192%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +174%
X Year: XXXXXXXXX +123%
1-Year High: XXXXXXX on 2025-09-29
1-Year Low: XXX on 2025-04-18

Engagements by network (24h): News: X Reddit: XX TikTok: X X: XXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXX +29%
X Months: XXXXX +118%
X Year: XXXXX +137%
1-Year High: XXX on 2025-09-29
1-Year Low: XX on 2025-01-27

Mentions by network (24h): News: X Reddit: XX TikTok: X X: XX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX -XX%
X Month: XXX +26%
X Months: XXXXX +165%
X Year: XXXXX +204%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-19

The most influential creators that mention MoonLake Immunotherapeutics Class A Ordinary Shares in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@Andre_AGTC	X	XXXXX	X	XXX
@Twills08	X	XXX	X	XX
@FluidBotStocks	X	XXX	X	XX
@Biotekster	X	XXX	X	XX

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% +20%
X Month: XXX% +28%
X Months: XXX% +11%
X Year: XXX% +65%
1-Year High: XXX% on 2025-01-26
1-Year Low: XX% on 2024-12-20

Most Supportive Themes:

Potential Buyout/Merger: (35%) Speculation about a potential buyout by a larger pharmaceutical company, particularly Merck, is a recurring theme, fueled by insider buying activity.
Positive Technical Analysis/Squeeze Potential: (25%) Some posts highlight potential for a short squeeze, with bullish technical analysis and mentions of institutional buying.
Focus on Psoriasis Pivot: (15%) Optimism surrounding the company's potential pivot to psoriasis treatment, with some seeing the recent negative data as an opportunity.

Most Critical Themes:

Concerns over Vela Phase X Study: (50%) The primary critical theme revolves around the failure of the sonelokimab drug to meet primary endpoints in the Vela phase X study for hidradenitis suppurativa.
Negative Data and Regulatory Pathway Uncertainty: (30%) Analysts are questioning the regulatory pathway and potential approval of the drug after it failed to meet primary endpoints.

Social Dominance: XXXXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
X Week: XXXXXXX% +0.00427%
X Month: XXXXXX% -XXXXXX%
X Months: XXXXXX% -XXXXXXXXXXXXXXXXXXXX%
X Year: XXXXXX% +0.0009999999999999992%
1-Year High: XXXX% on 2025-09-29
1-Year Low: XXXXXX% on 2025-02-27

Market Dominance: XXXXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-27
1-Year Low: XXXXXXX% on 2025-09-29

Market Cap: $XXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX -$4.90%
X Month: $XXXXXXXXXXXXX +$21%
X Months: $XXXXXXXXXXXXX -$64%
X Year: $XXXXXXXXXXXXX -$70%
1-Year High: $XXXXXXXXXXXXX on 2025-09-26
1-Year Low: $XXXXXXXXXXX on 2025-09-29

Top MoonLake Immunotherapeutics Class A Ordinary Shares News

Top news links shared on social in the last XX hours

Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.

"MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Institutional Holdings Nasdaq"
News Link @Nasdaq 2025-12-06T04:57Z 165.8K followers, XXX engagements

Top MoonLake Immunotherapeutics Class A Ordinary Shares Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Shorts will get crushed $KULR $KVUE $LAES $LASE $LFIN $LFLY $LGHL $LIDR $LILM $LMDX $LSTA $LTRY $LYT $MAC $MANH $MAPS $MARPS $MBRX $MCAC $MCLD $MCOM $MCRB $MEOA $METX $MFA $MGIH $MGNX $MICT $MIGI $MKFG $MLGO $MLTX $MMAT $MMV $MNTS $MOB $MOGO $MOTS $MOV $MRIN $MRKR $MRM"
X Link @SMALLCAPSAXIS 2025-12-09T16:25Z XXX followers, XXX engagements

"🔔 Markets open: Futures +0.1% amid Fed cut odds (87% Wed)S&P eyes 6900 yields XXXX% cap joy. $NVDA +2% on China H200 nod $GME pre-earnings🚀 (WSB YOLO calls). Reddit hypes $RIVN turnaround (+$2.4M bet) $MLTX run (+10% data leak). AZO/ AVAV reports: Auto boom vs. risk-off fade $BTC $90K flat. #FedWeek #MarketOpen"
X Link @TessT399016 2025-12-09T14:35Z XXX followers, XXX engagements

"- They also hold silver as a hedge but favor $MLTXs growth opportunity more. - Warning: $MLTX is small-cap and risky; options are illiquid with wide spreadsinvest only what you can afford to lose"
X Link @FluidBotStocks 2025-12-09T02:27Z XXX followers, XXX engagements

"- The author holds long-term stock and also some December 2025 call options as a lottery ticket for big gains aware of high timing risks and low option liquidity. - The poster shares personal struggles for transparency but remains confident $MLTX will provide financial gains"
X Link @FluidBotStocks 2025-12-09T02:27Z XXX followers, XXX engagements